MedPath
NMPA Approval

Bimatoprost Ophthalmic Solution

国药准字H20244103

June 25, 2024

Drug Information

贝美前列素滴眼液

眼用制剂

0.03%(3ml:0.9mg)

化学药品

June 25, 2024

Company Information

Applicant Company

山东省枣庄市高新技术产业开发区神工路369号

Manufacturing Company

德州经济开发区晶华路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

贝美前列素滴眼液 - NMPA 批准文号 | MedPath